logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Psychomotor Agitation

    FiltersReset Filters
    8 results

    • chlorpromazine

      (Chlorpromazine)
      Alembic Pharmaceuticals Limited
      Usage: This drug is indicated for managing symptoms of psychotic disorders, treating schizophrenia, controlling nausea and vomiting, relieving pre-surgical restlessness, managing acute intermittent porphyria, assisting in tetanus treatment, addressing manic-depressive illness, controlling intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

    • chlorpromazine hydrochloride

      (Chlorpromazine hydrochloride)
      Devatis, Inc.
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, relieving pre-surgery anxiety, managing acute intermittent porphyria, adjunctive treatment of tetanus, addressing manic episodes, and treating severe behavioral issues in children, including hyperactivity and conduct disorders.

    • chlorpromazine hydrochloride

      (chlorpromazine hydrochloride)
      Camber Pharmaceuticals, Inc.
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, and relieving restlessness before surgery. It also addresses acute intermittent porphyria, aids in tetanus treatment, manages mania, treats intractable hiccups, and handles severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

    • chlorpromazine hydrochloride

      (Chlorpromazine Hydrochloride)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, and treating acute intermittent porphyria. It also aids in tetanus treatment, addresses manic-depressive illness, relieves intractable hiccups, and treats severe behavioral issues in children aged 1 to 12.

    • chlorpromazine hydrochloride

      (CHLORPROMAZINE HYDROCHLORIDE)
      Eugia US LLC
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, managing pre-surgical anxiety, acute intermittent porphyria, tetanus alongside other treatments, and addressing manic episodes. It also helps alleviate intractable hiccups and severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

    • olanzapine

      (Olanzapine)
      Cadila Pharmaceuticals Limited
      Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), acute agitation in schizophrenia and bipolar I mania, and in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression. Use in adolescents requires careful risk assessment due to potential side effects.

    • oxazepam

      (Oxazepam)
      Actavis Pharma, Inc.
      Usage: Oxazepam is indicated for managing anxiety disorders and providing short-term relief of anxiety symptoms, including those associated with depression and alcohol withdrawal. It is particularly effective for older patients experiencing anxiety, tension, agitation, and irritability. Long-term efficacy beyond four months remains unassessed.

    • ziprasidone mesylate

      (Ziprasidone Mesylate)
      Fosun Pharma USA Inc.
      Usage: Ziprasidone mesylate for injection is indicated for the acute treatment of agitation in adult patients with schizophrenia who require rapid control. Caution is advised due to its potential to prolong the QT/QTc interval, which may lead to serious cardiac events. Co-administration with oral ziprasidone is not recommended.